These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 23469594)
1. [Observation of the curative effect of qingchang huashi recipe for treating active ulcerative colitis of inner-accumulation of damp-heat syndrome]. He HH; Shen H; Zheng K Zhongguo Zhong Xi Yi Jie He Za Zhi; 2012 Dec; 32(12):1598-601. PubMed ID: 23469594 [TBL] [Abstract][Full Text] [Related]
2. [Clinical study of comprehensive treatment of Chinese medicine in treating ulcerative colitis based on two steps according to the stage of disease]. Zhou T; Zhang SS; Cui C Zhongguo Zhong Xi Yi Jie He Za Zhi; 2012 Feb; 32(2):172-5. PubMed ID: 22574586 [TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of Fufangkushen colon-coated capsule in the treatment of ulcerative colitis compared with mesalazine: a double-blinded and randomized study. Gong Y; Zha Q; Li L; Liu Y; Yang B; Liu L; Lu A; Lin Y; Jiang M J Ethnopharmacol; 2012 Jun; 141(2):592-8. PubMed ID: 21911045 [TBL] [Abstract][Full Text] [Related]
4. [Effect of qingchang huashi recipe on IL-17 in the plasma and colonic mucosa of patients with ulcerative colitis]. Lu YL; Shen H; Yao HF; Yang X Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Oct; 34(10):1160-3. PubMed ID: 25509254 [TBL] [Abstract][Full Text] [Related]
5. [Effects of qingchang huashi recipe on the dendritic cells of the colonic mucosa and the mesenteric lymph nodes in experimental colitis rats]. Zhai JH; Shen H; Ni FF Zhongguo Zhong Xi Yi Jie He Za Zhi; 2012 Oct; 32(10):1366-9. PubMed ID: 23163148 [TBL] [Abstract][Full Text] [Related]
6. [Therapeutic effect and mechanisms study of Bawei Xilei Powder on ulcerative colitis patients]. Yan P; Qin O Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Jan; 34(1):27-30. PubMed ID: 24520782 [TBL] [Abstract][Full Text] [Related]
7. [Data mining of drug use rules based on traditional Chinese medicine treatment of ulcerative colitis]. Jia Y; Wang ZZ; Li XM; Miao MS Zhongguo Zhong Yao Za Zhi; 2021 May; 46(10):2594-2600. PubMed ID: 34047108 [TBL] [Abstract][Full Text] [Related]
9. [Study on discrimination mode of cold and hot properties of traditional Chinese medicines based on biological effects]. Huang LP; Zhu MF; Yu RY; Du JQ; Liu HN Zhongguo Zhong Yao Za Zhi; 2014 Sep; 39(17):3353-8. PubMed ID: 25522627 [TBL] [Abstract][Full Text] [Related]
10. [A multi-center randomized double-blinded, placebo-controlled clinical study on efficacy of composite sophora colon-soluble capsules in treating ulcerative colitis of internal dampness-heat accumulation syndrome type]. Tong ZQ; Yang B; Tong XY Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 Feb; 31(2):172-6. PubMed ID: 21425568 [TBL] [Abstract][Full Text] [Related]
11. Combined oral and enema treatment with Pentasa (mesalazine) is superior to oral therapy alone in patients with extensive mild/moderate active ulcerative colitis: a randomised, double blind, placebo controlled study. Marteau P; Probert CS; Lindgren S; Gassul M; Tan TG; Dignass A; Befrits R; Midhagen G; Rademaker J; Foldager M Gut; 2005 Jul; 54(7):960-5. PubMed ID: 15951542 [TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of a new 3.3 g b.i.d. tablet formulation in patients with mild-to-moderately-active ulcerative colitis: a multicenter, randomized, double-blind, placebo-controlled study. Scherl EJ; Pruitt R; Gordon GL; Lamet M; Shaw A; Huang S; Mareya S; Forbes WP Am J Gastroenterol; 2009 Jun; 104(6):1452-9. PubMed ID: 19491859 [TBL] [Abstract][Full Text] [Related]
13. [Clinical observation on effect of shaogen decoction for the prevention and treatment of acute radiation esophagitis]. Zhang J; Zhang L; Wang J Zhongguo Zhong Xi Yi Jie He Za Zhi; 2010 Dec; 30(12):1272-4. PubMed ID: 21302489 [TBL] [Abstract][Full Text] [Related]
14. [Effect of qingchang huash recipe on NF-kappaB/Tolls pathway in ulcerative colitis patients and mechanism study]. Shen H; Liu ZQ; Zhu Q; Zhu L; Zhai JH Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Sep; 33(9):1216-20. PubMed ID: 24273977 [TBL] [Abstract][Full Text] [Related]
15. Beclomethasone dipropionate versus mesalazine in distal ulcerative colitis: a multicenter, randomized, double-blind study. Biancone L; Gionchetti P; Blanco Gdel V; Orlando A; Annese V; Papi C; Sostegni R; D'Incà R; Petruzziello C; Casa A; Sica G; Calabrese E; Campieri M; Pallone F Dig Liver Dis; 2007 Apr; 39(4):329-37. PubMed ID: 17347061 [TBL] [Abstract][Full Text] [Related]
16. Mesalamine once daily is more effective than twice daily in patients with quiescent ulcerative colitis. Dignass AU; Bokemeyer B; Adamek H; Mross M; Vinter-Jensen L; Börner N; Silvennoinen J; Tan G; Pool MO; Stijnen T; Dietel P; Klugmann T; Vermeire S; Bhatt A; Veerman H Clin Gastroenterol Hepatol; 2009 Jul; 7(7):762-9. PubMed ID: 19375519 [TBL] [Abstract][Full Text] [Related]
17. Once daily MMX mesalazine for the treatment of mild-to-moderate ulcerative colitis: a phase II, dose-ranging study. D'Haens G; Hommes D; Engels L; Baert F; van der Waaij L; Connor P; Ramage J; Dewit O; Palmen M; Stephenson D; Joseph R Aliment Pharmacol Ther; 2006 Oct; 24(7):1087-97. PubMed ID: 16984503 [TBL] [Abstract][Full Text] [Related]
18. [Treatment of severe active systemic lupus erythematosus by PMC therapy combined langchuang fuzheng jiedu capsule: a clinical observation]. Song XW; Tang WJ; Guan TR; Dai QD; Zhang Y; Wu YJ Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Oct; 33(10):1315-9. PubMed ID: 24432670 [TBL] [Abstract][Full Text] [Related]
19. [Treatment of chronic primary glomerulopathy patients of Shen deficiency and dampness heat syndrome by yishen qingli granule combined low-dose Tripterygium wilfordii multiglycoside tablet: a clinical efficacy observation]. Sheng MX; Sun W; Xing CY; Yuan FH; Tang SF; Xiong PH; Ma JP; Zhou D; Gao K; Jiang Y; Chen JH; Mao HJ; Mou J; Luo YZ; Wei MG; Liu CX Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Dec; 33(12):1636-41. PubMed ID: 24517060 [TBL] [Abstract][Full Text] [Related]
20. Delayed-release oral mesalamine at 4.8 g/day (800 mg tablet) for the treatment of moderately active ulcerative colitis: the ASCEND II trial. Hanauer SB; Sandborn WJ; Kornbluth A; Katz S; Safdi M; Woogen S; Regalli G; Yeh C; Smith-Hall N; Ajayi F Am J Gastroenterol; 2005 Nov; 100(11):2478-85. PubMed ID: 16279903 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]